Research Article
The Impact of Migrations on the Health Services for Rare Diseases in Europe: The Example of Haemoglobin Disorders
Table 2
Disease burden with the expected births and the number of known patients.
| Countries | Expected thalassaemia births/1000 live births | Expected SCD births/1000 live births | Number of known or estimated patients with thalassaemia syndromes | Number of known or estimated patients with sickle cell syndromes |
| (1) Austria | 0.0015 | 0.00008 | NA | NA | (2) Belgium | 0.002 | 0.0035 | 100 | 400 | (3) Cyprus | 5.5 | 0.0018 | 639 | 40 | (4) Denmark | 0.0018 | 0.00004 | NA | NA | (5) France | 0.0016 | 0.0018 | 571 | 10000 | (6) Germany | 0.0016 | 0.0001 | 1500 | 3000 | (7) Greece | 1.6 | 0.009 | 3241 | 1080 | (8) Italy | 0.46 | 0.11 | 7000 | 6000 | (9) The Netherlands | 0.0018 | 0.0008 | 250 | 750 | (10) Spain | 0.067 | 0.0011 | 113 | >200 | (11) Sweden | 0.0025 | 0.00021 | 50 | 100 | (12) UK | 0.0018 | 0.0013 | 920 | 15000 |
|
|